For Patients With Isolated Cleft Palate Does Revision Palatoplasty Have an Increased Risk of Inpatient Complication Compared to Primary Palatal Repair?


Journal

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
ISSN: 1545-1569
Titre abrégé: Cleft Palate Craniofac J
Pays: United States
ID NLM: 9102566

Informations de publication

Date de publication:
01 2021
Historique:
pubmed: 18 8 2020
medline: 29 4 2021
entrez: 18 8 2020
Statut: ppublish

Résumé

The purpose of this study was to determine whether revision palatoplasty was associated with increased rates of inpatient complication and wound dehiscence compared to primary palatal repair. This was a retrospective study of patients with isolated cleft palate treated with primary palatoplasty or revision surgery for fistula repair. The records were obtained from the Kids' Inpatient Database between 2000 and 2014. The primary predictor was the type of surgery, classified as either primary or revision palatoplasty. Secondary predictors included demographics and comorbidities. Primary study outcomes were the postoperative complication and dehiscence rates as noted during the hospitalization course. The secondary outcomes related to health care utilization as measured through length of stay (LOS) and hospital charges. A total of 5357 total admissions (95.5% primary, 4.5% revision) were included in the final sample. Fistula repairs (odds ratio = 14.37, Although the rates of inpatient complications were not significantly different, revision palatoplasty was associated with a greater odds of wound dehiscence. Failure of a primary repair may portend an increased risk of wound failure with subsequent surgeries.

Identifiants

pubmed: 32799652
doi: 10.1177/1055665620949121
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

72-77

Auteurs

Kevin C Lee (KC)

Division of Oral and Maxillofacial Surgery, 25065NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY, USA.

Steven Halepas (S)

Division of Oral and Maxillofacial Surgery, 25065NewYork-Presbyterian/Columbia University Irving Medical Center, New York, NY, USA.

Brendan W Wu (BW)

Department of Oral and Maxillofacial Surgery, 12297New York University Langone Medical Center and Bellevue Hospital Center, New York, NY, USA.

Sung-Kiang Chuang (SK)

Department of Oral and Maxillofacial Surgery, 6572University of Pennsylvania Health System, Philadelphia, PA, USA.
Brockton Oral and Maxillofacial Surgery Inc, Brockton, MA, USA.
Department of Oral and Maxillofacial Surgery, Good Samaritan Medical Center, Brockton, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH